Sensitivity and performance of three novel quantitative assays of SARS-CoV-2 nucleoprotein in blood
Abstract To assess if SARS-CoV-2 (COVID-19) systemic disease can be determined by available nucleoprotein assays, we compared the performance of three commercial SARS-CoV-2 nucleoprotein (N) assays in plasma. A total of 272 plasma samples collected in the period November–December 2021 were analyzed...
Main Authors: | Thore Hillig, Josephine R. Kristensen, Claus L. Brasen, Ivan Brandslund, Dorte A. Olsen, Camilla Davidsen, Jonna S. Madsen, Claus A. Jensen, Young B. L. Hansen, Lennart Friis-Hansen |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-29973-3 |
Similar Items
-
Rapid SARS-CoV-2 Detection Using Electrochemical Immunosensor
by: Biljana Mojsoska, et al.
Published: (2021-01-01) -
The Soluble Urokinase-Type Plasminogen Activator Receptor as a Biomarker for Survival and Early Treatment Effect in Metastatic Colorectal Cancer
by: Kristian Blomberg, et al.
Published: (2021-10-01) -
Establishing Sex-Dependent Reference Intervals for KL-6 in Danish Adults
by: Stine Bakkensen Bruun, et al.
Published: (2023-06-01) -
Pentraxin 3 in the cerebrospinal fluid during central nervous system infections: A retrospective cohort study.
by: Martin Munthe Thomsen, et al.
Published: (2023-01-01) -
Pentraxin 3 in the cerebrospinal fluid during central nervous system infections: A retrospective cohort study
by: Martin Munthe Thomsen, et al.
Published: (2023-01-01)